Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19 (Prevention)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT06452654
What this trial is testing

Anti-viral Action Against Type 1 Diabetes Autoimmunity

Who this might be right for
Diabetes Mellitus, Type 1
Technical University of Munich 2,252
Not applicableNot Yet RecruitingNCT07516977
What this trial is testing

Noseguard for Prevention of Respiratory Infections in Real-World Use

Who this might be right for
Respiratory Infection VirusCOVID-19Influenza
Daewoong Pharmaceutical Co. LTD. 2,000
Large-scale testing (Phase 3)Study completedNCT04333732
What this trial is testing

CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION

Who this might be right for
COVID 19
Washington University School of Medicine 3,411
Not applicableUnknownNCT04421391
What this trial is testing

QuadraMune(TM) for Prevention of COVID-19

Who this might be right for
Covid19CoronavirusSARS-CoV 2
Therapeutic Solutions International 500
Large-scale testing (Phase 3)Active Not RecruitingNCT04948203
What this trial is testing

Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis

Who this might be right for
Pulmonary FibrosisCOVID-19 PneumoniaLong COVID
University of Chicago 60
Testing effectiveness (Phase 2)Study completedNCT04337918
What this trial is testing

Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection

Who this might be right for
Corona Virus Infection
Sanotize Research and Development corp. 143
Testing effectiveness (Phase 2)Study completedNCT04551547
What this trial is testing

Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of COVID-19

Who this might be right for
COVID-19
Sinovac Research and Development Co., Ltd. 552
Not applicableUnknownNCT04370015
What this trial is testing

Hydroxychloroquine Chemoprophylaxis for COVID-19 Infection in High-risk Healthcare Workers.

Who this might be right for
SARS-CoV-2Healthcare Workers
Services Institute of Medical Sciences, Pakistan 374
Not applicableStudy completedNCT05461378
What this trial is testing

PREP (Pre-Exposure Prophylaxis) of COVID-19

Who this might be right for
Immuno-DeficiencyCOVID-19
Ghady Haidar 138
Testing effectiveness (Phase 2)Study completedNCT05886816
What this trial is testing

Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19

Who this might be right for
SARS-CoV InfectionCOVID-19
University of Texas Southwestern Medical Center 122
Early research (Phase 1)UnknownNCT04462848
What this trial is testing

Covid-19 Convalescent Plasma as Prevention and Treatment for Children With Underlying Medical Conditions

Who this might be right for
Corona Virus Infection
University of California, Los Angeles 30
Not applicableStudy completedNCT04720404
What this trial is testing

Mindful Prevention of Psychopathology in Healthcare Workers During the COVID-19 Crisis (COVID-19 MindPreP)

Who this might be right for
MindfulnessRandomized Controlled TrialPsychopathology+1 more
Radboud University Medical Center 201
Not applicableUnknownNCT04587258
What this trial is testing

Improving Cancer Screening and Prevention During the COVID-19 Pandemic in Underserved Populations of Rhode Island

Who this might be right for
Breast CancerColorectal CancerCovid19
Rhode Island Hospital 100
Testing effectiveness (Phase 2)Study completedNCT05196581
What this trial is testing

Efficacy of Breathox Device Inhalation Therapy in the Treatment of Acute Symptoms Associated With COVID-19 and in the Prevention of the Use of Health Resources

Who this might be right for
COVID-19
Suzana Erico Tanni Minamoto 100
Testing effectiveness (Phase 2)Study completedNCT04962893
What this trial is testing

Study of a Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Virus-like Particle (VLP) Vaccine

Who this might be right for
Covid19
Ihsan GURSEL, PhD, Prof. 349
Testing effectiveness (Phase 2)UnknownNCT04713488
What this trial is testing

An Open Study on the Safety, Tolerability, and Immunogenicity of "Sputnik Light" Vaccine

Who this might be right for
COVID-19 Prevention
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 110
Not applicableStudy completedNCT04456062
What this trial is testing

Using Caring Contacts to Reduce Psychiatric Morbidity Following Hospitalization During the COVID-19 Pandemic

Who this might be right for
Psychiatric Hospitalization
Sunnybrook Health Sciences Centre 102
Testing effectiveness (Phase 2)Study completedNCT05446961
What this trial is testing

Clinical Study to Evaluate the Effect of Food Supplement in People Infected With Coronavirus

Who this might be right for
COVID-19 Virus Infection
SENAI CIMATEC 224
Testing effectiveness (Phase 2)UnknownNCT05248373
What this trial is testing

Safety, Tolerability and Immunogenicity of Gam-COVID-Vac Vaccine in a Nasal Spray

Who this might be right for
COVID-19SARS-CoV-2 Acute Respiratory Disease
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 400
Very early researchUnknownNCT05679466
What this trial is testing

An Investigator Initiated, Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Immunogenicity and Efficacy of the Recombinant Two-component COVID-19 Vaccine (CHO Cell) in Adults Aged 18 Years and Older

Who this might be right for
Prevention of COVID-19 Caused by SARS-CoV-2
Yu Qin 3,300
Next Page